Efficacy and Safety of Auto-FMT in Preventing aGVHD — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Efficacy and Safety of Auto-FMT in Preventing aGVHD — Stella

Home/Graft Versus Host Disease, Acute/

View on ClinicalTrials.gov

Recruiting

Back to Graft Versus Host Disease, Acute trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Ye Zhao, Suzhou, Jiangsu

Key details

Sponsor

The First Affiliated Hospital of Soochow University

Enrollment target

~100 participants

Started

March 2021

Primary completion

March 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years – 60 Years

Last updated December 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.